ERBB2 and breast carcinoma: Firstly, this study used results from RCTs conducted in Western countries (e.g., the effectiveness of trastuzumab in breast cancer patients with HER2+ and the probability of developing local regional or distant metastasis), which may not reflect the Vietnam context.